# Arbutus Biopharma Corp: Form 8-K, filed Jan 12, 2015

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2015-01-12
- Accepted by EDGAR: Jan 12, 2015, 17:26 ET
- Period: 2015-01-11
- Accession: 0001171843-15-000197
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000117184315000197/f8k_011215.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000117184315000197/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000117184315000197/f8k_011215.htm

Filed Jan 12, 2015.
Source: SEC EDGAR, the filing index for accession 0001171843-15-000197. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
